Chronic kidney disease: Is angiotensin system blockade indicated in the elderly?

[1]  S. Yusuf,et al.  Effect of Telmisartan on Renal Outcomes: A Randomized Trial , 2010 .

[2]  E. Larson,et al.  Current Guidelines for Using Angiotensin-Converting Enzyme Inhibitors and Angiotensin IIReceptor Antagonists in Chronic Kidney Disease: Is the Evidence Base Relevant to Older Adults? , 2009, Annals of Internal Medicine.

[3]  S. Yusuf,et al.  Effects of Ramipril and Rosiglitazone on Cardiovascular and Renal Outcomes in People With Impaired Glucose Tolerance or Impaired Fasting Glucose , 2008, Diabetes Care.

[4]  J. Coresh,et al.  Prevalence of chronic kidney disease in the United States. , 2007, JAMA.

[5]  J. Kaufman,et al.  Age affects outcomes in chronic kidney disease. , 2007, Journal of the American Society of Nephrology : JASN.

[6]  B. Davis,et al.  Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2005, Archives of internal medicine.

[7]  Bruce Kupelnick,et al.  K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease , 2004 .

[8]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[9]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.